What's Behind Acadia Pharmaceuticals' Mixed Q3 Results
Acadia Pharmaceuticals (NASDAQ: ACAD) has taken investors on something of a wild ride so far in 2020. There have been multiple share price swings of 20% or more this year. After a nice rise in recent weeks, Acadia could be headed for yet another downturn.
The drugmaker announced its third-quarter results after the market closed on Wednesday. Here are the highlights from Acadia's Q3 update.
Image Source: Getty Images.
Source Fool.com
